Drugs / Suxiao Jiuxin Pill
Suxiao Jiuxin Pill
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT06531161 | Aug → Sep 2024 overdue | acute mountain sickness | Peking University First Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Suxiao Jiuxin Pill | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06531161 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Suxiao Jiuxin Pill is a traditional Chinese medicine compound” NCT06531161 ↗ |